Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Am Acad Dermatol. 2011 Apr 29;65(1):25–34. doi: 10.1016/j.jaad.2010.09.016

Table II.

Clinical findings of antimelanoma differentiation-associated gene 5 patients

Total
(N = 77), N (%)
anti-MDA5-positive
(N = 10), N (%)
anti-MDA5-negative
(N = 67), N (%)
P value
Age onset, y ± SD 48.2 ± 16 51.5 ± 8.8 47.7 ± 16.8 .50
Female 51 (65) 7 (87.5) 44 (63.8) .25
Cancer 12 (15.6) 0 (0) 12 (17.9) .347
Tobacco use 19 (26) 1 (10) 18 (29) .438
Raynaud 13 (25) 3 (38) 10 (22) .389
Interstitial lung disease 16 (25) 6 (67) 10 (18) .005
    Rapidly progressive lung disease 5 (6.6) 2 (22.2) 3 (4.5) .104
Hand swelling 9 (13.8) 4 (40) 5 (9.1) .026
Arthritis/arthralgia 20 (31.2) 7 (70) 13 (24) .0076
Amyopathic 10 (13) 3 (30) 7 (10) .117
    Clinically amyopathic 13 (16.9) 5 (50) 8 (11.9) .010
Skin ulceration (any) 20 (26.0) 8 (80) 12 (18) .0002
    Ulceration (Gottron) 5 (6.5) 3 (30) 2 (3) .0142
    Ulceration (digit pulp/periungual) 11 (14.3) 8 (80) 3 (4.5) <.0001
    Ulceration (elbow) 4 (5.2) 3 (30) 1 (1.5) .0061
    Ulceration (chest/arms) 6 (7.8) 0 (0) 6 (9) 1.000
Palmar papules 7 (9.6) 6 (60) 1 (1.6) <.0001
Mechanic hands 15 (22.4) 6 (67) 9 (15.5) .0028
Panniculitis 2 (3.1) 2 (20) 0 (0) .0216
Calcinosis cutis 3 (4.8) 1 (11.1) 2 (3.7) .375
Alopecia 22 (34) 7 (78) 15 (27) .0053
Heliotrope rash 42 (60) 7 (70) 35 (58) .729
Gottron papules 38 (53.5) 7 (70) 31 (51) .32
Violaceous erythema
    Scalp 42 (62.7) 6 (67) 36 (62) 1.00
    Face 57 (80.3) 10 (100) 47 (77) .193
    V area of the chest-neck 54 (79.4) 8 (89) 46 (78) .673
    Elbow/knee 48 (69.6) 10 (100) 46 (78) .0259
Periungual telangiectasia 50 (73.6) 9 (90) 41 (71) .27
Pruritus 44 (68.8) 6 (67) 38 (69) 1.00
Oral pain/ulcers 9 (13.9) 5 (50) 4 (7.3) .0029

Statistically significant associations (P < 0.05) are shown in bold.

MDA5, Melanoma differentiation-associated gene 5.